Stacie Turner

CDR Stacie Turner, MSC, USN, serves as a key contracting leader within Navy Medicine East (N68908), where she oversees the acquisition of critical biomedical and medical technology systems essential to sustaining operational readiness for Navy and Marine Corps personnel. Her portfolio centers on procuring laboratory instrumentation, point-of-care diagnostic equipment, pharmaceutical preparations, and biomedical maintenance services that directly support clinical care and combat medical readiness. CDR Turner ensures acquisitions align with DoD standards and Navy Medicine’s strategic modernization goals, managing full lifecycle contracts from solicitation through performance evaluation, with a focus on mission-critical, high-reliability medical systems. While specific contractor names are not publicly disclosed, CDR Turner maintains a broad network of vendors spanning medical device manufacturers, pharmaceutical preparers, and biomedical service providers. She fosters partnerships with firms capable of delivering compliant, FDA-regulated, and MIL-SPEC-certified solutions, often requiring rigorous technical validation and supply chain traceability. Her contracting approach emphasizes vendor reliability, technical innovation, and rapid response capabilities to support expeditionary medical operations. CDR Turner’s procurement patterns reflect a strong preference for open competition, with 88.9% of awards issued without set-asides, indicating a focus on broad market access for mission-critical capabilities. Nevertheless, she consistently allocates 11.1% of opportunities to Total Small Business Set-Asides under FAR 19.5, demonstrating a measured but intentional commitment to small business participation without compromising operational urgency or technical integrity. Her primary NAICS focus areas include 811219 (Medical and Diagnostic Laboratory Services), 325412 (Pharmaceutical Preparation Manufacturing), 334513 (Industrial Process Measurement and Control Instrument Manufacturing), and 541512 (Computer Systems Design Services). These reflect deep expertise in procuring analytical lab systems, life-sustaining pharmaceuticals, diagnostic hardware, and integrated health IT platforms that enable data-driven clinical decision-making in austere environments.